Key terms
About STAA
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest STAA news
Mar 18
7:22am ET
Staar Surgical Highlights Milestone and Investor Engagement
Mar 12
8:36pm ET
Staar Surgical initiated with an Outperform at CICC
Mar 12
7:22am ET
STAAR Surgical Enhances Board with Strategic Appointments
Mar 11
4:45am ET
Staar Surgical upgraded to Buy from Hold at Stifel
Mar 11
4:36am ET
Buy Rating Affirmed for Staar Surgical Amidst Growth Potential and Market Headwinds
Feb 28
5:44pm ET
Staar Surgical’s Financial Performance Conference Overview
Feb 28
7:27am ET
Staar Surgical price target lowered to $45 from $50 at Mizuho
Feb 27
8:28am ET
Staar Surgical price target raised to $32 from $31 at Canaccord
Feb 27
7:43am ET
Piper Sandler Remains a Hold on Staar Surgical (STAA)
Feb 27
7:41am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), IQVIA Holdings (IQV) and Bausch Health Companies (BHC)
Feb 27
7:27am ET
Staar Surgical price target lowered to $33 from $40 at Piper Sandler
Feb 27
6:02am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)
Feb 26
4:02pm ET
Staar Surgical sees FY24 revenue $335M-$340M, consensus $348.96M
Feb 26
4:02pm ET
Staar Surgical reports Q4 EPS 16c, consensus 17c
Feb 13
8:27am ET
Buy Rating Justified for Staar Surgical Amidst Chinese Market Dominance and US Strategic Enhancements
Jan 23
7:05am ET
Staar Surgical announces strategic pact in U.S. with SharpeVision, no terms
Jan 22
7:05am ET
Staar Surgical price target lowered to $31 from $33 at Canaccord
Jan 10
9:10pm ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Elanco Animal Health (ELAN)
Jan 09
7:48am ET
Staar Surgical: A Hold Rating Amid Mixed Performance and Cautious 2024 Outlook
Jan 08
3:49pm ET
Fly Insider: Athira Pharma, Microstrategy among week’s notable insider trades
Jan 08
9:01am ET
Analysts Conflicted on These Healthcare Names: Schrodinger (SDGR), Accelerate Diagnostics (AXDX) and Staar Surgical (STAA)
Jan 08
7:17am ET
Staar Surgical sees FY24 revenue $335M -$340M, consensus $366.8M
Jan 08
7:15am ET
Staar Surgical sees FY23 revenue $$322.5M , consensus $320.5M
Jan 08
7:13am ET
Staar Surgical sees Q4 revenue $$76.5M, consensus $74.23M
Jan 08
2:31am ET
Insider Trading: Staar Surgical Stock (NASDAQ:STAA) Gained After $6.5M Insider Purchase
Jan 07
5:48am ET
BTIG Keeps Their Hold Rating on Staar Surgical (STAA)
Jan 02
9:52am ET
BTIG Sticks to Its Hold Rating for Staar Surgical (STAA)
Jan 02
9:51am ET
Analysts Conflicted on These Healthcare Names: Staar Surgical (STAA), Venus Concept (VERO) and Eli Lilly & Co (LLY)
Dec 31
5:27am ET
BTIG Sticks to Its Hold Rating for Staar Surgical (STAA)
No recent news articles are available for STAA
No recent press releases are available for STAA
STAA Financials
Key terms
Ad Feedback
STAA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
STAA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range